Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 7/20 | 0.49 |
| ▸ | MAOA | P21397 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL407381 | 0.89 | MAOB (0.50) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| Thiourea SCHEMBL6715523 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| Iodoacetamide SCHEMBL2218893 | 0.88 | SMN1; SMN2 (0.48) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL3933571 | 0.87 | PGR (0.47) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL30241252 | 0.84 | MAOB (0.54) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL28996736 | 0.84 | MAOB (0.54) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL27715978 | 0.82 | SMN1; SMN2 (0.41) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL259563 | 0.81 | HPGD (0.55) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL28180663 | 0.81 | MEN1 (0.44) | SMN1; SMN2NPC1RAB9AHPGDLMNA | |
| SCHEMBL2030045 | 0.81 | CYP19A1 (0.75) | SMN1; SMN2NPC1RAB9AHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2543 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235567-A1 | DNAZYME DETECTION OF METAL IONS AND GENE EXPRESSION IN TISSUES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-13 | — | — | WO | claimed |
| US-12419956-B2 | Controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof | THE UNIVERSITY OF HONG KONG (CN) | 2025-09-23 | — | — | US | claimed |
| WO-2025007135-A9 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | claimed |
| CN-113151407-B | Revealing modified nucleotide and nucleic acid interactions in single cells | 西格马-奥尔德里奇有限责任公司 | 2025-03-25 | — | — | CN | claimed |
| CN-116179554-B | Conditional protein targeted degradation chimeric based on nucleic acid aptamer, and preparation method and application thereof | 山东师范大学 | 2025-03-04 | — | — | CN | claimed |
| CN-116217560-B | N, N-diethylaminocoumarin compound and preparation method and application thereof | 浙江工业大学 | 2025-01-14 | — | — | CN | claimed |
| WO-2025007135-A2 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-01-02 | — | — | WO | claimed |
| CN-115427031-B | Controlled drug release systems of light responsive nanocarriers, methods of making and using the same | 香港大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118931906-A | 10-23DNAzyme capable of controlling light-operated bioorthogonal regulation and preparation method and application thereof | 兰州交通大学 | 2024-11-12 | — | — | CN | claimed |
| US-20240277867-A1 | A PHOTORESPONSIVE DELIVERY SYSTEM BASED ON A MODIFIED PAMAM AND METHODS THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2024-08-22 | — | — | US | claimed |
| EP-1356084-A2 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN, INC. (US) | 2003-10-29 | — | — | EP | claimed |
| WO-2003084333-A1 | VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS | ONCOIMMUNIN, INC. (US) | 2003-10-16 | — | — | WO | claimed |
| EP-0988394-A4 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN INC (US) | 2003-04-23 | — | — | EP | claimed |
| WO-2002061038-A9 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN INC (US) | 2002-11-28 | — | — | WO | claimed |
| WO-2002061038-A2 | HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES | ONCOIMMUNIN, INC. (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1214445-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2002-06-19 | — | — | EP | claimed |
| WO-2001018238-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2001-03-15 | — | — | WO | claimed |
| EP-0988394-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 2000-03-29 | — | — | EP | claimed |
| US-6037137-A | FLUORESCENT COMPOUND FOR SCREENING CLEAVING ACTIVITY AND STRUCTURAL CHANGES OF ENZYMATIC PROTEINS | ONCOIMMUNIN, INC. (US) | 2000-03-14 | — | — | US | claimed |
| WO-1998037226-A1 | COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF | ONCOIMMUNIN, INC. (US) | 1998-08-27 | — | — | WO | claimed |